DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 1Octavius Pharma Pvt. Ltd
03 1AADI SUB
04 3Alkem Laboratories
05 1Amneal Pharmaceuticals
06 1Apotex Inc
07 3Ascent Innovative Medicines
08 3Glenmark Pharmaceuticals
09 1Hetero Drugs
10 30Johnson & Johnson
11 1MSN Laboratories
12 4Murli Krishna Pharma
13 1Nobelpharma America
14 1Novitium Pharma LLC
15 1ORIFARM GROUP AS
16 4Panacea Biotec Limited
17 16Pfizer Consumer Healthcare
18 29Pfizer Inc
19 1Plusultra Pharma Gmbh
20 1Rising Pharmaceuticals Inc
21 1Torrent Pharmaceuticals Limited
22 3Zydus Pharmaceuticals
01 3Antic-calc Tablet, drasjert
02 11Coated Tablet
03 30DES
04 1GEL;TOPICAL
05 1Gel
06 4Granules For Tablet
07 1Granules for Tablets
08 2Oral Solid Dosage Form
09 4Oral Solution
10 1POWDER;INTRAVENOUS
11 1Potion, resolution
12 1SOLUTION
13 8SOLUTION;ORAL
14 1Sirolimus 0.5Mg 100 Unita' Oral Use
15 1Sirolimus 1Mg 100 Unita' Oral Use
16 1Sirolimus 1Mg/Ml 60Ml Oral Use
17 1Sirolimus 2Mg 30 Joined' Oral Use
18 1TAB
19 1TABLET
20 15TABLET;ORAL
21 8Tablet
22 4oral
23 12tablet
01 4Allowed
02 5Approved
03 5Authorized
04 2DISCN
05 1Deregistered
06 2Lead Market Dossiers- Approved in US
07 2Lead Market Dossiers- Filed
08 31Originator
09 2Prescription
10 23RX
11 36Blank
01 1CRB08225(1)CYPHER SELECT PLUS 8 X 2.25mm
02 1CRB08250(1)CYPHER SELECT PLUS 8 X 2.5mm
03 1CRB08275(1)CYPHER SELECT PLUS 8 X 2.75mm
04 1CRB08300(1)CYPHER SELECT PLUS 8 X 3mm
05 1CRB08350(1)CYPHER SELECT PLUS 8 X 3.5mm
06 2CRB13225(1)CYPHER SELECT PLUS 13 X 2.25mm
07 1CRB13275(1)CYPHER SELECT PLUS 13 X 2.75mm
08 1CRB13300(1)CYPHER SELECT PLUS 13 X 3mm
09 1CRB13350(1)CYPHER SELECT PLUS 13 X 3.5mm
10 1CRB18225(1)CYPHER SELECT PLUS 18 X 2.25mm
11 1CRB18250(1)CYPHER SELECT PLUS 18 X 2.5mm
12 1CRB18275(1)CYPHER SELECT PLUS 18 X2.75mm
13 1CRB18300(1)CYPHER SELECT PLUS 18 X 3mm
14 1CRB18350(1)CYPHER SELECT PLUS 18 X 3.5mm
15 1CRB23225(1)CYPHER SELECT PLUS 23 X 2.25mm
16 1CRB23250(1)CYPHER SELECT PLUS 23 X 2.5mm
17 1CRB23275(1)CYPHER SELECT PLUS 23 X 2.75mm
18 1CRB23300(1)CYPHER SELECT PLUS 23 X 3mm
19 1CRB23350(1)CYPHER SELECT PLUS 23 X 3.5mm
20 1CRB28225(1)CYPHER SELECT PLUS 28 X 2.25mm
21 1CRB28250(1)CYPHER SELECT PLUS 28 X 2.5mm
22 1CRB28275(1)CYPHER SELECT PLUS 28 X 2.75mm
23 1CRB28300(1)CYPHER SELECT PLUS 28 X 3mm
24 1CRB28350(1)CYPHER SELECT PLUS 28 X 3.5mm
25 1CRB33225(1)CYPHER SELECT PLUS 33 X 2.25mm
26 1CRB33250(1)CYPHER SELECT PLUS 33 X 2.5mm
27 1CRB33275(1)CYPHER SELECT PLUS 33 X 2.75mm
28 1CRB33300(1)CYPHER SELECT PLUS 33 X 3mm
29 1CRB33350(1)CYPHER SELECT PLUS 33 X 3.5mm
30 1FYARRO
31 1HYFTOR
32 1Hyftor
33 7RAPAMUNE
34 38Rapamune
35 1Rapamune 1mg
36 18SIROLIMUS
37 1Sirolimus
38 15Blank
01 16Australia
02 2Canada
03 16India
04 4Italy
05 4Norway
06 31South Africa
07 5Spain
08 6Sweden
09 4Switzerland
10 25USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2014-10-27
Application Number : 201578
Regulatory Info : RX
Registration Country : USA
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Sirolimus
Dosage Form : Granules for Tablets
Dosage Strength : 0.3; 0.6; 1.2%; %; %
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2014-10-27
Application Number : 201578
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in US
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : SOLUTION;ORAL
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2019-10-18
Application Number : 211212
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2020-10-16
Application Number : 208691
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-16
Application Number : 208691
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-16
Application Number : 208691
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : SOLUTION;ORAL
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 2019-01-28
Application Number : 211040
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAPAMUNE
Dosage Form : SOLUTION;ORAL
Dosage Strength : 1MG/ML
Packaging :
Approval Date : 1999-09-15
Application Number : 21083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAPAMUNE
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2000-08-25
Application Number : 21110
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAPAMUNE
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2002-08-22
Application Number : 21110
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RAPAMUNE
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2004-02-23
Application Number : 21110
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RAPAMUNE
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2010-01-25
Application Number : 21110
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2023-02-15
Application Number : 201676
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2023-02-15
Application Number : 201676
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SIROLIMUS
Dosage Form : TABLET;ORAL
Dosage Strength : 0.5MG
Packaging :
Approval Date : 2014-01-08
Application Number : 201676
Regulatory Info : RX
Registration Country : USA
